Heart Hospital of New Mexico at Lovelace Medical Center and GE HealthCare Collaborate to Install the First Allia IGS Pulse Electrophysiology Lab in the United States for Minimally Invasive Cardiovascular Procedures





Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) and GE HealthCare have announced the installation of the first Allia Image Guided System (IGS) Pulse in the United States. The Allia IGS Pulse is designed to enhance image quality and workflow in cardiovascular disease diagnosis and treatment. This advanced system will be employed in HHNM’s cardiac electrophysiology lab for procedures like cardiac ablations, catheterizations, and valve replacements. Dr. Sean Mazer emphasized the system’s ability to handle patients of all sizes and improve surgical outcomes. Brian Miller, CEO of HHNM, noted the hospital’s dedication to innovative heart care. Arnaud Marie of GE HealthCare highlighted the collaboration as a testament to GE’s commitment to healthcare advancements.

Positive


  • HHNM is the first U.S. location to install the Allia IGS Pulse, showcasing early adoption of advanced technology.

  • The system improves workflow and image quality for cardiovascular procedures, potentially leading to better patient outcomes.

  • The Allia IGS Pulse can accommodate patients of all sizes, including those with a BMI over 30.

  • Enhanced imaging capabilities may reduce surgical time and improve precision.

  • The collaboration strengthens the relationship between GE HealthCare and Lovelace Health System.

Negative


  • There is no guarantee that other hospitals will achieve the same results with the Allia IGS Pulse due to varying hospital settings.

The installation of the Allia IGS Pulse system at Heart Hospital of New Mexico is a significant milestone for both GE HealthCare and the medical field. This advanced imaging technology aims to enhance the precision and effectiveness of cardiovascular procedures, which can be a game-changer in cardiology. The fact that this system can accommodate patients of any size, including those with higher BMI, is particularly noteworthy. This adaptability can potentially lead to better patient outcomes and shorter procedure times, which are important in a field where time and accuracy are of the essence.

From a financial perspective, this installation could position GE HealthCare as a leader in the cardiovascular imaging market, which is already significant and growing. Hospitals and medical centers may look to adopt similar technologies, providing GE HealthCare with a competitive edge.

However, it’s essential to scrutinize the performance metrics once the system is in use. Initial positive feedback is encouraging, but long-term data on outcomes and cost-effectiveness will be vital for widespread adoption.

From a clinical standpoint, the Allia IGS Pulse system’s ability to provide exceptional image quality is a significant advancement. High-quality imaging is critical for the success of electrophysiological procedures such as cardiac ablations and coronary angioplasties. These procedures require pinpoint accuracy and better imaging can reduce the risk of complications and improve patient outcomes.

The system’s flexibility to create personalized workspaces for clinicians is another notable feature. This customization can enhance workflow efficiency, allowing more procedures to be performed in less time. In the long run, this could lead to increased patient throughput and potentially lower healthcare costs.

For retail investors, the collaboration between Heart Hospital of New Mexico and GE HealthCare is a positive indicator of GE HealthCare’s continued innovation and market penetration. The U.S. market for cardiovascular treatment is vast, given the high prevalence of heart disease and this new installation positions GE HealthCare favorably.

Investors should also note the potential ripple effects of this news. Hospitals and medical centers may follow suit, opting for similar high-tech solutions to stay competitive. This could drive revenue growth for GE HealthCare in the coming years. However, it’s essential to stay informed about the system’s real-world performance and whether it meets the high expectations set by this initial announcement.









ALBUQUERQUE, N.M.–(BUSINESS WIRE)–
Today Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) and GE HealthCare (Nasdaq: GEHC) announced HHNM as the first location in the United States to install GE HealthCare’s latest Allia Image Guided System (IGS) Pulse, which was designed to provide exceptional image quality and improve workflow for the diagnosis and treatment of cardiovascular diseases (CVD). HHNM will use the Allia IGS Pulse system in its cardiac electrophysiology (EP) lab to plan, guide and monitor the outcomes of electrophysiological procedures, such as cardiac ablations, cardiac catherizations, transcatheter aortic valve replacements, balloon and coronary angioplasties and more.

“This advanced imaging technology allows me and my fellow clinicians to perform complex cardiology interventions with a high level of precision and exceptional image quality,” said Sean Mazer, M.D., FHRS, FACC, electrophysiologist and president of the New Mexico Heart Institute/Lovelace Medical Group*. “We can accommodate patients of any size and the system provides us with a personalized workspace that meets our specific needs and preferences, resulting in shorter surgical time and better outcomes for our patients.”

According to the 2024 Heart Disease and Stroke Statistics: A Report of U.S. and Global Data From the American Heart Association, heart disease has been the leading cause of death in the U.S. for one hundred years – with nearly half (48.6%) of all people over the age of 20 years old having some type of cardiovascular disease (CVD), including coronary heart disease, heart failure, stroke and, most notably, high blood pressure.

“It’s an honor to have the U.S.’s first Allia IGS Pulse system at Heart Hospital of New Mexico,” said Brian Miller, chief executive officer of HHNM*. “As New Mexico’s only hospital dedicated exclusively to care of the heart, we pride ourselves on providing innovative treatment options for our patients, keeping them close to home for care.”

HHNM clinicians are equipped with an adaptable, versatile solution for a wide range of clinical situations and procedures. The Allia IGS Pulse system is designed to help improve clinician workflow while also providing exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size – including large and bariatric patients with a BMI of greater than 30.

“GE HealthCare has had a long-standing relationship with Lovelace Health System and has witnessed its ongoing leadership in providing the best possible care to its patients,” said Arnaud Marie, General Manager for Interventional at GE HealthCare. “We are delighted to collaborate with them for the first U.S. installation of the Allia IGS Pulse System. This next step is a demonstration of our commitment to addressing today’s healthcare challenges, unlocking efficiencies, and most importantly, providing optimal experiences for patients and their providers.”

Click here to learn more about GE HealthCare’s Allia Pulse and Image Guided solutions.

*The statements by GE HealthCare’s customers described here are based on their own opinions and on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist, i.e. hospital size, case mix, etc.. there can be no guarantee that other customers will achieve the same results.

**This product may not be available in your country or region. Please contact your GE HealthCare representative or visit our website for more information.

About Heart Hospital of New Mexico at Lovelace Medical Center

Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) is New Mexico’s only hospital dedicated exclusively to cardiovascular care, including the state’s only facility performing left ventricular assist device (LVAD) implants and was recently re-credentialed by DNV through 2026 as a Ventricular Assist Device Facility. The 55-bed facility, which features a state-of-the-art hybrid operating room where surgeons can perform advanced surgical services for cardiovascular patients, has become synonymous with high quality, technologically advanced cardiac care. HHNM was named a fourth consecutive Top Teaching Hospital from 2020 – 2023 by Leapfrog Hospital Safety for its quality of care, including practices for safer surgery and capacity to prevent medication errors and has three times been named to The Best Hospital in America List for 2021 – 2023 (small teaching hospital category) by Money and the Leapfrog Group for its quality, safe care, a reputation for excellent patient experiences and an ethical approach to treatment. To learn more about the state-of-the-art treatment options, innovative health care providers and award-winning quality initiatives at Heart Hospital of New Mexico at Lovelace Medical Center, visit hearthospitalnm.com.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.

Follow us on LinkedIn, X (formerly Twitter), Facebook, Instagram, and Insights for the latest news, or visit our website for more information.

Media Contacts:

Whitney Alcantar

Lovelace Health System

[email protected]

505.727.5503

Sara Pottle

GE HealthCare

USCAN Communications Specialist

[email protected]

Emily Niles

GE HealthCare

Global Communications Director – IGT

[email protected]

Source: GE HealthCare








FAQ



What is the Allia IGS Pulse system?


The Allia IGS Pulse is an advanced image-guided system designed by GE HealthCare for improving the diagnosis and treatment of cardiovascular diseases.


Where was the first Allia IGS Pulse system installed in the U.S.?


The first Allia IGS Pulse system in the U.S. was installed at Heart Hospital of New Mexico at Lovelace Medical Center.


What procedures will the Allia IGS Pulse be used for at HHNM?


At HHNM, the Allia IGS Pulse will be used for electrophysiological procedures, including cardiac ablations, catheterizations, and valve replacements.


How does the Allia IGS Pulse benefit patients and clinicians?


The Allia IGS Pulse provides exceptional imaging quality and workflow improvements, accommodating patients of all sizes, which can lead to shorter surgical times and better outcomes.


What is the significance of the collaboration between HHNM and GE HealthCare?


The collaboration marks a significant step in advancing cardiovascular care and demonstrates GE HealthCare’s commitment to innovative healthcare solutions.






link

Leave a Reply

Your email address will not be published. Required fields are marked *